| HOME >> BIOLOGY >> TECHNOLOGY |
OMAHA, Neb., March 18 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced financial results for the fourth quarter and year ended December 31, 2008. The Company's financial results are presented in the tables that follow.
The Company reported a net loss of $219,000 or $0.00 per share for the fourth quarter of 2008 as compared to a net income of $212,000 or $0.00 per share for the fourth quarter of 2007.
Net sales from continuing operations were $6.1 million during the fourth quarter 2008, compared to $6.5 million during the comparable period of 2007. Gross profit from continuing operations was $3.4 million or 55 percent during the fourth quarter of 2008 compared to $3.9 million or 60 percent during the comparable period of 2007. Operating expenses from continuing operations were $3.4 million during the fourth quarter of 2008 compared to $3.7 million during the same period of 2007. The $3.4 million in operating expenses included a $638,000 goodwill impairment charge and income from foreign currency revaluation of $0.5 million. Cash and cash equivalents totaled $4.8 million at December 31, 2008.
The Company reported a net loss of $495,000 or $0.01 per share for the year ended December 31, 2008, compared to a net loss of $2.1 million or $0.04 per share for the year ended December 31, 2007. The 2007 net loss was comprised of a loss from continuing operations of $2.2 million or $0.04 per share and an income from discontinued operations of $67,000.
Net sales from continuing operations were $24.0 million for the year ended December 31, 2008, compared to $23.2
'/>"/>
| SOURCE Transgenomic, Inc. Copyright©2009 PR Newswire. All rights reserved |